Olympus gets behind bowel cancer research


Olympus Australia & New Zealand has thrown its support behind bowel cancer research by entering into a formal partnership with Bowel Cancer Australia.

The partnership was sealed late last year when Olympus, a leading manufacturer of opto-digital products, presented the charity with a $22,000 donation.

Olympus and Bowel Cancer Australia have previously worked together on an ad hoc basis.

But Oliver Clarke, Olympus’ communications manager, said the affiliation was formally recognised at an event in October.

“We have now formalised the partnership at the corporate level to make the most effective use of the company and staff's support for the charity's activities so that our impact is more significant,” Mr Clarke said.

Bowel cancer is the second most common cancer in both men and women in Australia.

Around 17,000 people are diagnosed each year, with the disease most common in people over the age of 50.

Many hospitals around the country use Olympus’ products to detect and treat the cancer.

Surgeons use endoscopes to find polyps and other potential pre-cancerous indications of bowel cancer, while other devices made by Olympus are used to treat patients with the disease.

Mr Clarke said the company had taken steps to educate staff by distributing information packs to its branches throughout Australia.

“The disease is 100% treatable if caught early,” he said. “By increasing awareness of the disease we can encourage people to seek regular check-ups.”


Comments are closed.